128 related articles for article (PubMed ID: 6282486)
1. VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Mortimer J; Bukowski RM; Montie J; Hewlett JS; Livingston RB
Cancer Chemother Pharmacol; 1982; 7(2-3):215-8. PubMed ID: 6282486
[TBL] [Abstract][Full Text] [Related]
2. VP-16-213 (etoposide) in the management of germinal testis tumors.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
[No Abstract] [Full Text] [Related]
3. Etoposide salvage therapy for refractory germ cell tumors: an update.
Williams SD; Einhorn LH
Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
[No Abstract] [Full Text] [Related]
4. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
5. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
[No Abstract] [Full Text] [Related]
7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
8. [VM-26 salvage therapy for refractory or recurrent germinal testicular cancers].
Miki T; Oda H; Saiki S; Kinouchi T; Kuroda M; Kiyohara H; Usami M; Kotake T
Hinyokika Kiyo; 1985 Sep; 31(9):1649-56. PubMed ID: 4083220
[TBL] [Abstract][Full Text] [Related]
9. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
Bosl GJ; Yagoda A; Golbey RB; Whitmore W; Herr H; Sogani P; Morse M; Vogelzang N; MacDonald G
Am J Med; 1985 Mar; 78(3):423-8. PubMed ID: 2983547
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.
Hainsworth JD; Williams SD; Einhorn LH; Birch R; Greco FA
J Clin Oncol; 1985 May; 3(5):666-71. PubMed ID: 2582097
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of refractory germ cell cancer with Etoposide.
Lederman GS; Garnick MB; Canellos GP; Richie JP
J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
[TBL] [Abstract][Full Text] [Related]
12. Reversal of recurrent laryngeal nerve palsy following VP16-213 combination therapy in a patient with metastatic teratoma of the testis.
Rubery ED
Cancer Chemother Pharmacol; 1982; 7(2-3):219-21. PubMed ID: 6177438
[TBL] [Abstract][Full Text] [Related]
13. [VP-16 salvage therapy of PVB regimen-resistant testicular germ cell tumors].
Yamazaki H; Yuichiro A; Kondo N; Imanaka K; Machida T
Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1227-31. PubMed ID: 2446041
[No Abstract] [Full Text] [Related]
14. Possible benefit of doxorubicin treatment in patients with refractory germ cell cancer.
Lederman GS; Garnick MB
Cancer; 1986 Dec; 58(11):2393-8. PubMed ID: 2429755
[TBL] [Abstract][Full Text] [Related]
15. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
17. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
18. Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor.
Chi EA; Schweizer MT
Clin Genitourin Cancer; 2017 Oct; 15(5):e855-e857. PubMed ID: 28465048
[No Abstract] [Full Text] [Related]
19. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
Harstrick A; Schmoll HJ; Wilke H; Köhne-Wömpner CH; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
J Clin Oncol; 1991 Sep; 9(9):1549-55. PubMed ID: 1651992
[TBL] [Abstract][Full Text] [Related]
20. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]